Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis.
Journal: Cancer investigation
Published: May 13, 2025
Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: March 03, 2022
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review.
Journal: Clinical hypertension
Published: July 07, 2021
Fatal Adverse Events Associated with Pembrolizumab in Cancer Patients: A Meta-Analysis.
Journal: Cancer investigation
Published: January 28, 2020
Increased Risk of Hypertension with Enzalutamide in Prostate Cancer: A Meta-Analysis.
Journal: Cancer investigation
Published: September 27, 2019
Emerging therapeutic agents for genitourinary cancers.
Journal: Journal of hematology & oncology
Published: June 15, 2019
Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma.
Journal: Translational cancer research
Published: June 07, 2019
Risk of hypertension in Cancer patients treated with Abiraterone: a meta-analysis.
Journal: Clinical hypertension
Published: November 19, 2018
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis.
Journal: Clinical hypertension
Published: November 19, 2018
Incidence and risk of developing photosensitivity with targeted anticancer therapies.
Journal: Journal of the American Academy of Dermatology
Published: July 31, 2018
An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma.
Journal: Expert opinion on biological therapy
Published: May 22, 2018
Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma.
Journal: Current oncology reports
Published: April 04, 2018
Last Updated: 09/26/2026